The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 08, 2025

Filed:

Sep. 27, 2021
Applicant:

Livanova Usa, Inc., Houston, TX (US);

Inventors:

Imad Libbus, St. Paul, MN (US);

Badri Amurthur, Los Gatos, CA (US);

Bruce H. KenKnight, Maple Grove, MN (US);

Assignee:

LivaNova USA, Inc., Houston, TX (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61N 1/365 (2006.01); A61B 5/363 (2021.01); A61N 1/36 (2006.01);
U.S. Cl.
CPC ...
A61N 1/365 (2013.01); A61B 5/363 (2021.01); A61N 1/36114 (2013.01); A61N 1/36139 (2013.01); A61N 1/36167 (2013.01); A61N 1/36175 (2013.01); A61N 1/36171 (2013.01);
Abstract

A method for managing bradycardia through vagus nerve stimulation is provided. An implantable neurostimulator configured to deliver electrical therapeutic stimulation in both afferent and efferent directions of a patient's cervical vagus nerve is provided. An operating mode is stored, which includes parametrically defining a maintenance dose of the electrical therapeutic stimulation tuned to restore cardiac autonomic balance through continuously-cycling, intermittent and periodic electrical pulses. The maintenance dose is delivered via a pulse generator through a pair of helical electrodes via an electrically coupled nerve stimulation therapy lead independent of cardiac cycle. The patient's physiology is monitored, and upon sensing a condition indicative of bradycardia, the delivery of the maintenance dose is suspended. A progressively increasing amount of time is spent waiting via a controller and, upon sensing a condition indicative of an absence or termination of the bradycardia, a progressively increasing partial maintenance dose is delivered via the pulse generator.


Find Patent Forward Citations

Loading…